Breed's Hill Capital’s CME Group CME Stock Holding History

Breed's Hill Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$293K	Hold	1,062	–	–	0.14%	98
2025 Q1	$282K	Hold	1,062	–	–	0.15%	98
2024 Q4	$247K	Buy	+1,062	New	+$244K	0.13%	104

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Breed's Hill Capital's CME Position: Q2 2025 in Review

Breed's Hill Capital held its CME Group (CME) position steady in Q2 2025 at 1,062 shares worth $293K. The position accounts for 0.14% of the portfolio, ranked #98.

Breed's Hill Capital first reported a position in CME in Q4 2024 and has held it in 3 quarters since. 1,662 funds tracked by Wall St. Rank hold CME as of Q2 2025.

Breed's Hill Capital held 1,062 shares of CME Group worth $293K as of Q2 2025.
Breed's Hill Capital left its CME Group share count unchanged in Q2 2025.
CME Group made up 0.14% of Breed's Hill Capital's portfolio in Q2 2025, its #98 holding.
Breed's Hill Capital first reported a position in CME Group in Q4 2024 and has held it in 3 quarters since.
1,662 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.